Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination
S. J. Tsai, C. Guo, A. Sedgwick, S. Kanagavelu, J. Nice, S. Shetty, C. Landaverde, N. A. Atai, S. J. Gould
This paper develops exosome-based mRNA vaccines that express SARS-CoV-2 antigens, showing long-lasting immune responses and fewer adverse effects than lipid nanoparticles.
bioRxiv · Nov 6, 2020 · PreprintImmunology